Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP886039.RAZ-eF_sa-SJsra_hBlZ1CeuyLSlskkHPJA4MHk-ERkv0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP886039.RAZ-eF_sa-SJsra_hBlZ1CeuyLSlskkHPJA4MHk-ERkv0130_assertion type Assertion NP886039.RAZ-eF_sa-SJsra_hBlZ1CeuyLSlskkHPJA4MHk-ERkv0130_head.
- NP886039.RAZ-eF_sa-SJsra_hBlZ1CeuyLSlskkHPJA4MHk-ERkv0130_assertion description "[During hospitalization, percentages of na�ve (CD62L+, CD45RA+) CD4+ and CD8+ T lymphocytes decreased (P = 0.01 for both), and activated (HLA-DR+, CD25+, or CD69+) CD4+ and CD8+ T lymphocytes increased (P = 0.02 and 0.03, respectively).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP886039.RAZ-eF_sa-SJsra_hBlZ1CeuyLSlskkHPJA4MHk-ERkv0130_provenance.
- NP886039.RAZ-eF_sa-SJsra_hBlZ1CeuyLSlskkHPJA4MHk-ERkv0130_assertion evidence source_evidence_literature NP886039.RAZ-eF_sa-SJsra_hBlZ1CeuyLSlskkHPJA4MHk-ERkv0130_provenance.
- NP886039.RAZ-eF_sa-SJsra_hBlZ1CeuyLSlskkHPJA4MHk-ERkv0130_assertion SIO_000772 12829827 NP886039.RAZ-eF_sa-SJsra_hBlZ1CeuyLSlskkHPJA4MHk-ERkv0130_provenance.
- NP886039.RAZ-eF_sa-SJsra_hBlZ1CeuyLSlskkHPJA4MHk-ERkv0130_assertion wasDerivedFrom befree-20140225 NP886039.RAZ-eF_sa-SJsra_hBlZ1CeuyLSlskkHPJA4MHk-ERkv0130_provenance.
- NP886039.RAZ-eF_sa-SJsra_hBlZ1CeuyLSlskkHPJA4MHk-ERkv0130_assertion wasGeneratedBy ECO_0000203 NP886039.RAZ-eF_sa-SJsra_hBlZ1CeuyLSlskkHPJA4MHk-ERkv0130_provenance.